Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Cybin Inc (NY: CYBN ) 0.2680 UNCHANGED Streaming Delayed Price Updated: 8:00 PM EDT, Aug 23, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 1,380 Open 0.2680 Bid (Size) 0.2680 (1) Ask (Size) 0.2685 (8) Prev. Close 0.2680 Today's Range 0.2680 - 0.2680 52wk Range 0.2400 - 0.7380 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) Holds Initial Breakthrough Therapy Meeting with FDA, Plans for CYB003 Phase 3 Trial August 13, 2024 Via Investor Brand Network Exposures Product Safety Cybin Announces Completion of FDA Type B Initial Breakthrough Therapy Meeting and Plans for CYB003 Phase 3 Program in Major Depressive Disorder August 13, 2024 From Cybin Inc. Via Business Wire Performance YTD -33.00% -33.00% 1 Month -6.59% -6.59% 3 Month -23.41% -23.41% 6 Month -23.45% -23.45% 1 Year -15.00% -15.00% More News Read More CYBN Stock Earnings: Cybin Beats EPS for Q1 2024 August 09, 2024 Via InvestorPlace BioMedNewsBreaks — Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) Releases Q1 2025 Financial Results, Business Highlights August 08, 2024 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property CYBN Stock Earnings: Cybin Beats EPS for Q4 2023 June 26, 2024 Via InvestorPlace Cybin Reports First Quarter Fiscal Year 2025 Financial Results and Recent Business Highlights August 08, 2024 From Cybin Inc. Via Business Wire InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) CEO to Participate in a Fireside Chat at Upcoming Conference August 07, 2024 Via Investor Brand Network Cybin to Participate in the Canaccord Genuity 44th Annual Growth Conference August 07, 2024 From Cybin Inc. Via Business Wire EXCLUSIVE: Legal Magic Mushroom Products Will Be Sold In Jamaica As Psilocybin Products Hit Pharmacy Shelves July 31, 2024 Via Benzinga 3 Biotech Stocks That Could Make Your Summer Unforgettable July 30, 2024 Via InvestorPlace Cybin Inc. Stands Strong As A Remaining Force To Prove Benefits Of Psychedelic Therapeutics ($CYBN) July 10, 2024 Via AB Newswire Exposures Product Safety PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) Sees “Swell” of Insider Investments, Upgrade in Ranking after Positive Year-End Report July 08, 2024 Via Investor Brand Network Psychedelic Picks: 3 Trippy Stocks Aiming for Out-of-This-World Returns July 03, 2024 Via InvestorPlace 3 Psychedelic Stocks to Buy on the Dip: Summer 2024 July 02, 2024 Via InvestorPlace Biopharma Co. Cybin Reports $78M Loss Amid Accelerating Expansion In Psychedelic Therapies, Drug Development June 26, 2024 Via Benzinga Cybin Reports Fiscal Year 2024 Financial Results and Recent Business Highlights June 26, 2024 From Cybin Inc. Via Business Wire InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) CEO Featured Presenter at Upcoming H.C. Wainwright Neuro Perspectives Virtual Conference June 20, 2024 Via Investor Brand Network InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) Releases FY Financial Report, Business Update June 26, 2024 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property Product Safety Cybin to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference June 19, 2024 From Cybin Inc. Via Business Wire Latest Executive Cannabis Changes You Should Know About: Curaleaf, Planet 13 Elect Directors And More June 18, 2024 Via Benzinga Topics Cannabis Exposures Cannabis InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) Announces Strategic Appointment of Dr. Atul Mahableshwarkar June 11, 2024 Via Investor Brand Network Exposures Product Safety Cybin Appoints Dr. Atul Mahableshwarkar M.D., as Senior Vice President, Clinical Development June 11, 2024 From Cybin Inc. Via Business Wire Psychedelic Stocks Trip Up After FDA Advisors Reject MDMA For PTSD Treatment June 05, 2024 Via Benzinga Exposures Product Safety InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) Announces Participation at Interdisciplinary Conference on Psychedelic Research 2024 May 29, 2024 Via Investor Brand Network Cybin to Participate at the Pathways to Access Summit and the Interdisciplinary Conference on Psychedelic Research 2024 May 29, 2024 From Cybin Inc. Via Business Wire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.